Poster: MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma
Jeffrey A. Zonder, Joshua Richter, Naresh Bumma, Jason Brayer, James E. Hoffman, William I. Bensinger, Ka Lung Wu, Linzhi Xu, Dhruti Chokshi, Anita Boyapati, …
Clinical lymphoma, myeloma and leukemia, Vol.22, p.S178
Poster: MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma
Creators
Jeffrey A. Zonder - The Barbara Ann Karmanos Cancer Institute
Joshua Richter
Naresh Bumma
Jason Brayer
James E. Hoffman
William I. Bensinger
Ka Lung Wu
Linzhi Xu
Dhruti Chokshi
Anita Boyapati
Damien Cronier
Yariv Houvras
Karen Rodriguez Lorenc
Glenn S. Kroog
Madhav V. Dhodapkar
Suzanne Lentzsch
Dennis Cooper
Sundar Jagannath
Publication Details
Clinical lymphoma, myeloma and leukemia, Vol.22, p.S178
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology